a University of California Davis, Nutrition , Davis , California , USA.
b United States Department of Agriculture ARS, Western Human Nutrition Research Center , Davis , California , USA.
J Am Coll Nutr. 2018 Jan;37(1):44-50. doi: 10.1080/07315724.2017.1347908. Epub 2017 Oct 18.
Fatty acid profiles and desaturase (SCD-16, SCD018, D5D, D6D) and elongase (ELOVL6) enzyme activity have been associated with adiposity and metabolic disease. While this has been studied in adults, few studies have included children. The objective of this study was to evaluate these markers in children and identify relationships with markers of metabolic health. It was hypothesized that these lipid markers would be correlated to adiposity and metabolic disease.
This study was a cross-sectional analysis of fourth- and fifth-grade children (n = 86, aged 9-12) participating in a comprehensive nutrition program. Any student enrolled in the program was eligible for inclusion in this study. Fasting plasma was collected and analyzed for total fatty acids, glucose, insulin, and full lipid panels. Insulin resistance was estimated using calculated homeostatic model assessment for insulin resistance (HOMA-IR) values.
There were no differences in lipid markers, glucose, insulin, or HOMA-IR among children classified as normal weight, overweight, or obese. SCD-16, D5D, and ELOVL6 activity was significantly correlated to HOMA-IR values (r = 0.39, p = 0.001; r = -0.33, p = 0.006; r = -0.37, p = 0.005, respectively). In regression analysis, body mass index for age percentile, D6D activity, ELOVL6 activity, and systolic blood pressure were the most significant predictors of HOMA-IR values (adjusted r = 0.39, p ≤ 0.001).
There was no relationship between these lipid markers and adiposity in this population; however, there were correlations with HOMA-IR. Regardless of adiposity, there may be underlying changes in fatty acid and lipid metabolism associated with the development of metabolic diseases.
脂肪酸谱和去饱和酶(SCD-16、SCD018、D5D、D6D)和延伸酶(ELOVL6)的活性与肥胖和代谢性疾病有关。虽然这在成年人中已经进行了研究,但很少有研究包括儿童。本研究的目的是评估这些标志物在儿童中的表现,并确定它们与代谢健康标志物的关系。我们假设这些脂质标志物与肥胖和代谢性疾病有关。
这是一项对参加综合营养计划的四年级和五年级儿童(n=86,年龄 9-12 岁)进行的横断面分析。任何参加该计划的学生都有资格纳入本研究。采集空腹血浆并进行总脂肪酸、葡萄糖、胰岛素和全脂质谱分析。使用计算的稳态模型评估胰岛素抵抗(HOMA-IR)值来估计胰岛素抵抗。
根据体重指数(BMI)将儿童分为正常体重、超重和肥胖组,各组之间的脂质标志物、葡萄糖、胰岛素或 HOMA-IR 无差异。SCD-16、D5D 和 ELOVL6 的活性与 HOMA-IR 值显著相关(r=0.39,p=0.001;r=-0.33,p=0.006;r=-0.37,p=0.005)。在回归分析中,年龄百分位 BMI、D6D 活性、ELOVL6 活性和收缩压是 HOMA-IR 值的最显著预测因子(调整后的 r=0.39,p≤0.001)。
在该人群中,这些脂质标志物与肥胖之间没有关系;然而,它们与 HOMA-IR 存在相关性。无论肥胖程度如何,与代谢性疾病的发生相关的脂肪酸和脂质代谢可能存在潜在变化。